Long-Term Outcomes Among HIV-Infected Liver Transplant Recipients.

2014 ◽  
Vol 98 ◽  
pp. 774
Author(s):  
J. Locke ◽  
A. Massie ◽  
R. Reed ◽  
D. Segev
Surgery ◽  
2017 ◽  
Vol 162 (5) ◽  
pp. 1101-1111 ◽  
Author(s):  
Masato Fujiki ◽  
Koji Hashimoto ◽  
Emmanouil Palaios ◽  
Cristiano Quintini ◽  
Federico N. Aucejo ◽  
...  

2016 ◽  
Vol 64 (2) ◽  
pp. S155
Author(s):  
M. Stepanova ◽  
M. Sayiner ◽  
L. De Avila ◽  
Z. Younoszai ◽  
A. Racila ◽  
...  

2017 ◽  
Vol 21 (6) ◽  
pp. e12945 ◽  
Author(s):  
Udeme D. Ekong ◽  
Patrick McKiernan ◽  
Mercedes Martinez ◽  
Steven Lobritto ◽  
Deirdre Kelly ◽  
...  

2019 ◽  
Vol 156 (6) ◽  
pp. S-1249
Author(s):  
Sowmya Sharma ◽  
Kristel Leung ◽  
Rachel Kang ◽  
Lilia Antonova ◽  
Aloysious Aravinthan ◽  
...  

2019 ◽  
Vol 33 (12) ◽  
Author(s):  
Sammy Saab ◽  
Dana Song ◽  
Youssef P. Challita ◽  
Tina Xiwen Zhou ◽  
Elena G. Saab ◽  
...  

2017 ◽  
Vol 49 (6) ◽  
pp. 1425-1429 ◽  
Author(s):  
D.D. You ◽  
G.S. Choi ◽  
J.M. Kim ◽  
C.H.D. Kwon ◽  
J.-W. Joh ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
pp. e32-e38
Author(s):  
Cynthia Tsien ◽  
Huey Tan ◽  
Sowmya Sharma ◽  
Naaventhan Palaniyappan ◽  
Pramudi Wijayasiri ◽  
...  

2017 ◽  
Vol 37 (02) ◽  
pp. 095-108 ◽  
Author(s):  
Sotiris Mastoridis ◽  
Marc Martinez-Llordella ◽  
Alberto Sanchez-Fueyo

AbstractThe burden of life-long immunosuppressive medication must be overcome if progress is to be made in long-term outcomes following transplantation. The liver exhibits intrinsic tolerogenic properties that contribute to a unique propensity toward spontaneous acceptance when transplanted. Hence, a proportion of liver transplant recipients develop a state of immunotolerance and display persistently normal allograft function despite the discontinuation of immunosuppression. However, this phenomenon remains elusive for the majority of recipients. Investigations performed in experimental models of spontaneous liver allograft tolerance and in clinical cases of immunosuppression-free liver transplant acceptance have yielded mechanistic insights at the heart of recent strategies toward tolerance prediction and promotion. Results from recent clinical trials signal a shift in how liver allograft tolerance is viewed—not an elusive rarity of academic interest, but a potentially relevant clinical opportunity, which can be safely pursued if appropriately targeted.


Sign in / Sign up

Export Citation Format

Share Document